Syndax Pharmaceuticals Revenue

Biotechnology Research • 730 3rd Ave, Floor 9, United States • 201-500 Employees

Syndax Pharmaceuticals revenue & valuation

Annual revenue	$78,200,000
Revenue per employee	$226,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$250,200,000
Total funding	$580,000,000

Key Contacts at Syndax Pharmaceuticals

Kristin Zwanch

Director, Systems Of Care

Bryan Tierney

Director, Talent Acquisition & Experience

Brian Malloy

National Account Director

Patrick Hardesty

Director, Clinical Science Aml, Cgvhd, Ipf

Jorge Farias

Director, Health Outcomes Liaison West

Pierre Legault

Member Board Of Directors Chair Audit, Compensation, Strategic Committees, Nominating & Governance

Brett Goldberg

Director, Hcp Marketing

Jim Datz

National Executive Director, Payer Relations And Government Accounts

Ruchit Doshi

Senior Director, Gmp Quality Assurance, Commercial

Brad Jensen

Regional Business Director, Southeast Region

Company overview

Headquarters	730 3rd Ave, Floor 9, New York, NY 10017, US
Phone number	+17814191400
Website	syndax.com
NAICS	541714
SIC	283
Employees	201-500
Socials

Syndax Pharmaceuticals Email Formats

Syndax Pharmaceuticals uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@syndax.com), used 82.1% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@syndax.com	82.1%
{first initial}{last name}	jdoe@syndax.com	17.1%

About Syndax Pharmaceuticals

Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company’s pipeline include a menin inhibitor for R/R acute leukemia and a monoclonal antibody that blocks the CSF-1 receptor for chronic graft-versus-host disease. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment. Review our social media community guidelines below: https://syndax.com/social-media-community-guidelines/

Employees by Management Level

Total employees: 201-500

Seniority

Employees

Director

Manager

Entry

Employees by Department

Syndax Pharmaceuticals has 206 employees across 15 departments.

Departments

Number of employees

Funding Data

Explore Syndax Pharmaceuticals's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-01-14	14	$230,000,000
2024-12-04	16	$350,000,000

Funding Insights

$580,000,000

Total funding amount

$350,000,000

Most recent funding amount

Number of funding rounds

Syndax Pharmaceuticals Tech Stack

Discover the technologies and tools that power Syndax Pharmaceuticals's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Salesforce

CRM

Next.js

JavaScript frameworks

Google Tag Manager

Tag managers

GraphQL

Programming languages

Node.js

Programming languages

Apple iCloud Mail

Webmail

HTTP/3

Miscellaneous

Apollo

JavaScript libraries

Open Graph

Miscellaneous

HSTS

Security

Vimeo

Video players

Frequently asked questions

Syndax Pharmaceuticals is located in 730 3rd Ave, Floor 9, US.

You can reach Syndax Pharmaceuticals at +17814191400.

Syndax Pharmaceuticals generates an estimated annual revenue of $78,180,000. This revenue figure reflects the company's market position and business performance in its industry.

Syndax Pharmaceuticals has an estimated valuation of $250,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Syndax Pharmaceuticals has approximately 201-500 employees. The company continues to grow its workforce to support its business operations and expansion.

Syndax Pharmaceuticals has raised a total of $580,000,000 across 2 funding rounds. This investment has helped the company grow and expand its operations.